KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Dividends Paid - Common (2016 - 2025)

West Pharmaceutical Services' Dividends Paid - Common history spans 17 years, with the latest figure at $15.8 million for Q4 2025.

  • For Q4 2025, Dividends Paid - Common rose 3.27% year-over-year to $15.8 million; the TTM value through Dec 2025 reached $61.2 million, up 3.55%, while the annual FY2025 figure was $61.2 million, 3.55% up from the prior year.
  • Dividends Paid - Common for Q4 2025 was $15.8 million at West Pharmaceutical Services, up from $15.1 million in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $15.8 million in Q4 2025 and bottomed at $12.6 million in Q1 2021.
  • The 5-year median for Dividends Paid - Common is $14.1 million (2022), against an average of $14.1 million.
  • The largest annual shift saw Dividends Paid - Common grew 7.63% in 2023 before it increased 3.27% in 2025.
  • A 5-year view of Dividends Paid - Common shows it stood at $13.3 million in 2021, then rose by 6.02% to $14.1 million in 2022, then rose by 4.96% to $14.8 million in 2023, then rose by 3.38% to $15.3 million in 2024, then increased by 3.27% to $15.8 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Dividends Paid - Common are $15.8 million (Q4 2025), $15.1 million (Q3 2025), and $15.1 million (Q2 2025).